×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 3: Sustainability of the Biosimilar Medicines Sector
Session Chair(s)
Per Troein, MBA, MSc
VP Strategic Partners
IQVIA, United Kingdom
Speaker(s)
Towards a Sustainable European Market for off-Patent Biologics
Mareike Ostertag, DVM
Novartis AG, Switzerland
Global Head, Policy Strategy, Global Public Affairs
EU Policy Features in Support of Sustainable Biosimilar Competition – Industry Perspective
Florian Turk
Sandoz Biopharma, Germany
Global Head Payor Marketing, Sales and Engagement
Dorthe Bartels
Amgros I/S, Denmark
Strategic Advisor and Negotiator
Have an account?